Cornelius Miething
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Aging top 2%
Papers in
- Hematology 29
- Chronic Myeloid Leukemia Treatments 20
- Acute Myeloid Leukemia Research 11
- Genetics 17
- Chronic Lymphocytic Leukemia Research 16
Cornelius Miething
64 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hematology 863
- Aging 123
- Immunology 1.2k
- Oncology 1.5k
- Cancer Research 740
Countries citing papers authored by Cornelius Miething
This map shows the geographic impact of Cornelius Miething's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelius Miething with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelius Miething more than expected).
Fields of papers citing papers by Cornelius Miething
This network shows the impact of papers produced by Cornelius Miething. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelius Miething. The network helps show where Cornelius Miething may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cornelius Miething, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 76 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 2 | |
| 11 | 2018 | 16 | |
| 12 | 2018 | 9 | |
| 13 | 2014 | 31 | |
| 14 | 2014 | 38 | |
| 15 | 2012 | 20 | |
| 16 | 2008 | 93 | |
| 17 | Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Hit paper breakdown → | 2007 | 1914 |
| 18 | The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity | 2006 | 1 |
| 19 | 2003 | 14 | |
| 20 | 2003 | 34 |
About Cornelius Miething
Cornelius Miething is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Immunology, having authored 68 papers that have together received 5.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (16 papers), Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Eosinophilic Disorders and Syndromes (9 papers), Ubiquitin and proteasome pathways (8 papers), Cancer-related Molecular Pathways (7 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Hematology (863 citations), Aging (123 citations), Immunology (1.2k citations), Oncology (1.5k citations) and Cancer Research (740 citations). Cornelius Miething has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Scott W. Lowe, Ross A. Dickins, Lars Zender, Valery Krizhanovsky, Wen Xue, Eva Hernando, Carlos Cordon‐Cardo, Justus Duyster, Christian Peschel and Rebekka Grundler. Their work appears in journals such as Blood, Leukemia, Oncogene, Nature and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.